Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 1
1983 3
1984 2
1985 1
1986 1
1987 1
1988 1
1989 3
1990 12
1991 8
1992 6
1993 9
1994 12
1995 14
1996 21
1997 22
1998 20
1999 15
2000 29
2001 29
2002 14
2003 39
2004 31
2005 23
2006 34
2007 39
2008 63
2009 49
2010 54
2011 78
2012 102
2013 114
2014 129
2015 172
2016 170
2017 186
2018 199
2019 236
2020 314
2021 339
2022 364
2023 461
2024 499
2025 555
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,964 results

Results by year

Filters applied: . Clear all
Page 1
A lysosomal surveillance response to stress extends healthspan.
Li TY, Gao AW, Yang R, Sun Y, Lei Y, Li X, Chen L, Liu YJ, Arey RN, Morales K, Liu RB, Wang W, Zhou A, Zhao TJ, Li W, Lalou A, Wang Q, Lima T, Houtkooper RH, Auwerx J. Li TY, et al. Among authors: zhou a. Nat Cell Biol. 2025 Jul;27(7):1083-1097. doi: 10.1038/s41556-025-01693-y. Epub 2025 Jun 26. Nat Cell Biol. 2025. PMID: 40571723 Free PMC article.
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.
Wang Y, Zhang Y, Luo H, Wei W, Liu W, Wang W, Wu Y, Peng C, Ji Y, Zhang J, Zhu C, Bai W, Xia L, Lei H, Xu H, Yin L, Weng W, Yang L, Liu L, Zhou A, Wei Y, Zhu Q, Zhu W, Yang Y, Xu Z, Wu Y. Wang Y, et al. Among authors: zhou a. Acta Pharm Sin B. 2024 Dec;14(12):5235-5248. doi: 10.1016/j.apsb.2024.08.019. Epub 2024 Aug 28. Acta Pharm Sin B. 2024. PMID: 39807309 Free PMC article.
CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial.
Liu J, Yang J, Sun Y, Gong J, Yue J, Pan Y, Sun M, Song R, Xiao X, Tazbirkova A, Ruan J, Liu Z, Liu Z, Li Z, Sheng L, Qin Y, Ying J, Yu X, Zhang J, Mou Y, Lu C, Chen P, Li S, Li J, Qu X, Deng T, Du J, Zhou A, Li E, Yuan X, Liang X, Yu W, Morris M, Luo Y, Zhao X, Guo Y, Zhou H, Shen L. Liu J, et al. Among authors: zhou a. Nat Med. 2025 Sep;31(9):3028-3036. doi: 10.1038/s41591-025-03783-8. Epub 2025 Jul 16. Nat Med. 2025. PMID: 40670773 Free PMC article. Clinical Trial.
A Concise Synthesis of (2R,6R)-Hydroxynorketamine.
Li J, Zhou A, Wang X, Zhang W, Zhou Q, Li N. Li J, et al. Among authors: zhou a. J Org Chem. 2024 Nov 15;89(22):16909-16916. doi: 10.1021/acs.joc.4c01502. Epub 2024 Nov 1. J Org Chem. 2024. PMID: 39483090
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study.
Shi Y, Guo Y, Li X, Wu L, Chen Z, Yang S, Bi M, Zhao Y, Yao W, Yu H, Wang K, Zhao W, Sun M, Zhang L, He Z, Lin Y, Shi J, Zhu B, Wang L, Pan Y, Shi H, Sun S, Wen M, Zhou R, Guo S, Han Z, Yi T, Zhang H, Cang S, Yu Z, Zhong D, Cui J, Fang J, Gao J, Li M, Ma R, Jiang M, Qin J, Shu Y, Ye F, Hu S, Li W, Lu H, Yang M, Yi S, Zhang Y, Fan Y, Ji H, Liu Z, Wang H, Zhou X, Zhang D, Peng J, Shen H, Gao F, Wang T, Zhou A. Shi Y, et al. Among authors: zhou a. Lancet Respir Med. 2025 Apr;13(4):327-337. doi: 10.1016/S2213-2600(24)00417-X. Epub 2025 Feb 3. Lancet Respir Med. 2025. PMID: 39914443 Clinical Trial.
3,964 results